| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 11.068 | 33.896 | 25.569 | 13.653 |
| Total Income - EUR | - | - | - | - | - | - | 11.068 | 33.896 | 25.569 | 13.653 |
| Total Expenses - EUR | - | - | - | - | - | - | 8.902 | 21.166 | 16.581 | 15.414 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 2.165 | 12.730 | 8.988 | -1.761 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.834 | 12.037 | 8.732 | -2.170 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nkmedis21 S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 3.385 | 5.527 | 4.556 | 3.687 |
| Current Assets | - | - | - | - | - | - | 9.585 | 7.060 | 13.685 | 12.736 |
| Inventories | - | - | - | - | - | - | 7.524 | 5.173 | 10.244 | 11.761 |
| Receivables | - | - | - | - | - | - | 809 | 811 | 809 | 804 |
| Cash | - | - | - | - | - | - | 1.253 | 1.076 | 2.633 | 171 |
| Shareholders Funds | - | - | - | - | - | - | 1.834 | 12.041 | 18.539 | 13.028 |
| Social Capital | - | - | - | - | - | - | 0 | 0 | 0 | 40 |
| Debts | - | - | - | - | - | - | 11.136 | 546 | -298 | 3.394 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Nkmedis21 S.r.l.